Question: why did nvcn stock drop?
Answer: Neovasc CEO Alexei Marko with the heart valve that made it one of the darlings of B.c.'s life sciences sector. One of the stars of Vancouver's life sciences firmament began a meteoric fall Friday, when a U.S. court awarded a US$70 million judgment against Neovasc Inc. (TSX:NVC, Nasdaq:NVCN) for breaching trade secrets.